MUVOBA Trademark

Trademark Overview

On Wednesday, April 24, 2019, a trademark application was filed for MUVOBA with the United States Patent and Trademark Office. The USPTO has given the MUVOBA trademark a serial number of 88399889. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 3, 2023. This trademark is owned by Glaxo Group Limited. The MUVOBA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
muvoba

General Information

Serial Number88399889
Word MarkMUVOBA
Filing DateWednesday, April 24, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 3, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 31, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 9, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Monday, April 3, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 3, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 3, 2022SOU EXTENSION 5 GRANTED
Thursday, July 28, 2022SOU EXTENSION 5 FILED
Thursday, July 28, 2022SOU TEAS EXTENSION RECEIVED
Thursday, January 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 26, 2022SOU EXTENSION 4 GRANTED
Friday, January 14, 2022SOU EXTENSION 4 FILED
Wednesday, January 26, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 14, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, July 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 16, 2021SOU EXTENSION 3 GRANTED
Friday, July 16, 2021SOU EXTENSION 3 FILED
Friday, July 16, 2021SOU TEAS EXTENSION RECEIVED
Monday, March 29, 2021ASSIGNED TO EXAMINER
Friday, December 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 9, 2020SOU EXTENSION 2 GRANTED
Wednesday, December 9, 2020SOU EXTENSION 2 FILED
Wednesday, December 9, 2020SOU TEAS EXTENSION RECEIVED
Saturday, March 21, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 19, 2020SOU EXTENSION 1 GRANTED
Thursday, March 19, 2020SOU EXTENSION 1 FILED
Thursday, March 19, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, February 25, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 31, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 31, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 11, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 22, 2019ASSIGNED TO LIE
Tuesday, November 19, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 18, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 15, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 15, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 11, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 11, 2019NON-FINAL ACTION E-MAILED
Thursday, July 11, 2019NON-FINAL ACTION WRITTEN
Thursday, July 4, 2019ASSIGNED TO EXAMINER
Thursday, May 9, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 27, 2019NEW APPLICATION ENTERED

Related Keywords

muvoba pharmaceutical treatment preparations diseases disorders substances respiratory oncological genitourinary neurological